prednisone has been researched along with Hypogonadism in 10 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hypogonadism: Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarcoidosis is uncommon in children." | 1.34 | Isolated neurosarcoidosis presenting as headache and multiple brain and spinal cord lesions mimicking central nervous system metastases. ( Boue, DR; Henwood, MJ; Lo, WD; Rusin, JA; Tsao, CY, 2007) |
| "Hypogonadism has traditionally been classified as either hypogonadotropic or hypergonadotropic based on serum gonadotropin levels." | 1.32 | Acute stress masking the biochemical phenotype of partial androgen insensitivity syndrome in a patient with a novel mutation in the androgen receptor. ( Crowley, WF; Dwyer, AA; Hayes, FJ; McPhaul, MJ; Pitteloud, N; Villegas, J, 2004) |
| "Neurosarcoidosis was diagnosed in all patients." | 1.31 | Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. ( Bullmann, C; Faust, M; Heppner, C; Hoffmann, A; Jockenhövel, F; Krone, W; Müller-Wieland, D, 2000) |
| "A patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described." | 1.28 | Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases? ( Nikolaou, N; Orfanos, S; Pavlidis, N; Tolis, C; Tolis, G, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manosroi, W | 1 |
| Chirayucharoensak, J | 1 |
| Chai-Adisaksopha, C | 1 |
| Phinyo, P | 1 |
| Pitteloud, N | 1 |
| Villegas, J | 1 |
| Dwyer, AA | 1 |
| Crowley, WF | 1 |
| McPhaul, MJ | 1 |
| Hayes, FJ | 1 |
| Tsao, CY | 1 |
| Lo, WD | 1 |
| Rusin, JA | 1 |
| Henwood, MJ | 1 |
| Boue, DR | 1 |
| Ezrin, C | 1 |
| Briant, TD | 1 |
| Firestone, G | 1 |
| Rosen, F | 1 |
| Beck, W | 1 |
| Schwarz, S | 1 |
| Heidemann, PH | 1 |
| Jentsch, E | 1 |
| Stubbe, P | 1 |
| König, A | 1 |
| Bullmann, C | 1 |
| Faust, M | 1 |
| Hoffmann, A | 1 |
| Heppner, C | 1 |
| Jockenhövel, F | 1 |
| Müller-Wieland, D | 1 |
| Krone, W | 1 |
| Mack-Shipman, LR | 1 |
| Ratanasuwan, T | 1 |
| Leone, JP | 1 |
| Miller, SA | 1 |
| Lyden, ER | 1 |
| Erickson, JM | 1 |
| Larsen, JL | 1 |
| Pavlidis, N | 1 |
| Nikolaou, N | 1 |
| Tolis, C | 1 |
| Orfanos, S | 1 |
| Tolis, G | 1 |
| Kabadi, UM | 1 |
| De Moor, P | 1 |
| Steeno, O | 1 |
| Brosens, I | 1 |
| Hendrikx, A | 1 |
10 other studies available for prednisone and Hypogonadism
| Article | Year |
|---|---|
Hormonal Changes after R-CHOP Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Hypogonadism; | 2022 |
Acute stress masking the biochemical phenotype of partial androgen insensitivity syndrome in a patient with a novel mutation in the androgen receptor.
Topics: Androgen-Insensitivity Syndrome; Binding Sites; Giant Cell Arteritis; Glucocorticoids; Gonadal Stero | 2004 |
Isolated neurosarcoidosis presenting as headache and multiple brain and spinal cord lesions mimicking central nervous system metastases.
Topics: Adolescent; Anti-Inflammatory Agents; Brain; Central Nervous System Diseases; Central Nervous System | 2007 |
The endocrine aspects of trans-sphenoidal hypophysectomy.
Topics: Adrenal Glands; Breast Neoplasms; Cortisone; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans | 1967 |
Hypergonadotropic hypogonadism, SHBG deficiency and hyperprolactinaemia: a transient phenomenon during induction chemotherapy in leukemic children.
Topics: Adult; Asparaginase; Child, Preschool; Daunorubicin; Estradiol; Female; Follicle Stimulating Hormone | 1982 |
Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis.
Topics: Adult; Brain Diseases; Diabetes Insipidus, Neurogenic; Female; Humans; Hypogonadism; Immunosuppressi | 2000 |
Reproductive hormones after pancreas transplantation.
Topics: Adult; Body Mass Index; Cyclosporine; Dose-Response Relationship, Drug; Female; Gonadal Steroid Horm | 2000 |
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Hodgkin Dis | 1989 |
Onset of type I diabetes mellitus, hypothyroidism, and hypogonadism on withdrawal of glucocorticoid therapy and remission on its resumption in a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Diabetes Mellitus, Type 1; Humans; Hypogonadism; Hypothy | 1986 |
Data on transcortin activity in human plasma as studied by gel filtration.
Topics: Acromegaly; Addison Disease; Adolescent; Adult; Anorexia Nervosa; Child; Chromatography, Gel; Contra | 1966 |